Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Heron (HRTX) Q2 Acute Care Jumps 56%
Key PointsGAAP revenue of $37.2 million missed expectations by 2.3% in Q2 2025.Acute Care segment revenue surged 55.5%, while Oncology segment revenue declined 9.0%.Full-year 2025 adjusted EBITDA (non-GAAP) guidance was raised, reflecting operational progress and improved cost control.These 10 stock...
The Motley Fool
Fri, Aug 8
The Silver Lining in Ford's Messy Q2 Earnings
Key PointsThe U.S. automaker was set up for a strong sales quarter due to promotions.Tariffs negatively impacted second-quarter results to the tune of $800 million.However, management believes it's about to have another "Model T moment." 10 stocks we like better than Ford Motor Company › It turns ou...
The Motley Fool
Fri, Aug 8
Is Alphabet One of the Best Stocks to Buy Right Now?
A huge risk to Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) search engine business is keeping this stock trading at a relatively cheap valuation.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »*Stock prices used wer...
The Motley Fool
Fri, Aug 8
Cytokinetics rises as investors await US approval for heart drug
** Shares of drug developer Cytokinetics CYTK.O rise ~3% to $36.24 premarket** Co reported Q2 revenue of $66.8 million , compared with $0.2 million a year ago, helped by $52.4 million payment related to co's licensing deal for experimental heart disease drug, aficamten, in Japan with Germany'...
Reuters
Fri, Aug 8
Athira Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Athira Pharma Inc ATHA.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -70 cents. The mean expectation of two analysts for the quarter was for a loss of 18 cents per share. Reported...
Reuters
Fri, Aug 8
U.S. STOCKS ON THE MOVE-Pinterest, Novo Nordisk, Instacart
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures rose on Friday after President Donald Trump's temporary pick for a Federal Reserve governor fueled expectations of a more dovish policy ahead. .N ** Light & ...
Reuters
Fri, Aug 8
Sylvamo (SLVM) Q2 Revenue Falls 15%
Key PointsGAAP revenue fell to $794 million in Q2 2025, missing estimates by 3.9% and declining 14.9% year-over-year (GAAP).GAAP earnings per share were $0.37 in Q2 2025, below consensus and EPS was down 63.7% year over year.Segment results diverged: Europe swung to an operating loss (business segme...
The Motley Fool
Fri, Aug 8
Flutter (FLUT) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DATEThursday, Aug. 7, 2025, at 4:30...
The Motley Fool
Fri, Aug 8
Bicycle (BCYC) Q2 Revenue Falls 69%
Key PointsRevenue (GAAP) for Q2 2025 was $2.92 million, falling sharply short of the $9.43 million analyst estimate.Research and development expenses (GAAP) jumped 77.3% year over year in Q2 2025, primarily due to increased clinical program expenses for zelenectide pevedotin development, higher disc...
The Motley Fool
Fri, Aug 8
Parker-Hannifin Reports Record Sales
Parker-Hannifin(NYSE:PH) reported results for the fiscal fourth quarter and fiscal year ended June 30, 2025, on August 7, 2025, posting record sales of $19.9 billion and 7% year-over-year growth in adjusted EPS. The company achieved a record adjusted segment operating margin of 26.1%, ended the year...
The Motley Fool
Fri, Aug 8
Sotera Health (SHC) Q2 Revenue Up 6%
Key PointsGAAP revenue for Q2 2025 was $294 million, beating analyst expectations by $18.1 million, or 6.6%.Adjusted EPS was $0.20 for Q2 2025, topping the non-GAAP estimate of $0.17.Management raised full-year 2025 revenue and earnings guidance, reflecting improved performance in key segments.These...
The Motley Fool
Fri, Aug 8
Actelis Networks Inc
expected to post a loss of 16 cents a share - Earnings Preview
Actelis Networks Inc ASNS.OQ ASNS.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025The Fremont California-based company is expected to report revenue of $1 million, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst esti...
Reuters
Fri, Aug 8
AbCellera Biologics (ABCL) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DateThursday, August 7, 2025, at 5 ...
The Motley Fool
Fri, Aug 8
Rockwell Automation falls after Wells Fargo cuts rating, PT
** Shares of Rockwell Automation ROK.N down 1% at $329 in premarket trading** Wells Fargo downgrades rating to "equal weight" from "overweight", cuts PT to $345 from $365, a premium of 3.7% from the stock's last close** ROK on Wednesday raised the low end of its annual profit for...
Reuters
Fri, Aug 8
GLOBAL MARKETS-Stocks rise as investors eye Fed revamp; gold hits record
Markets eye dovish tilt at Fed as Miran appointedNasdaq futures rise, on track for third day of gainsGold futures jump on report of US tariffsBy Gregor Stuart Hunter and Amanda Cooper SINGAPORE/LONDON, Aug 8 (Reuters) - Global shares rose on Friday, along with the dollar, as investors clung to th...
Reuters
Fri, Aug 8
Monroe Capital jumps on merger deal with Horizon Technology Finance
** Specialty finance firm Monroe Capital Corp's MRCC.O shares jump 11.7% to $6.97 premarket** MRCC announced late on Thursday it will merge with Horizon Technology Finance HRZN.O, another business development company under Monroe Capital umbrella** HRZN and MRCC are both affiliates of asset mana...
Reuters
Fri, Aug 8
Akero (AKRO) Q2 Loss Narrows 6%
Key PointsAkero Therapeutics (NASDAQ:AKRO) reported a GAAP net loss per share of ($0.86) for Q2 2025, narrower than the consensus estimate of ($0.92).Key clinical trial results for efruxifermin (EFX) were published in the New England Journal of Medicine and highlighted at major scientific conference...
The Motley Fool
Fri, Aug 8
Are You Really Ready to Start Collecting Social Security? 3 Signs It Might Be the Perfect Time.
Key PointsYour health plays a huge role in determining the best time to collect Social Security.Also key is if your savings, pensions, or part-time work aren't enough to keep you afloat.If you’re married, your decision may affect your spouse and how much they’re eligible to collect.The $23,760 Socia...
The Motley Fool
Fri, Aug 8
Kiora (KPRX) Q2 Revenue Falls 100%
Key PointsRevenue for the period was $0, missing the analyst estimate of $0.75 million and down from $0.02 million in Q2 2024.Clinical pipeline progress continued, with new Phase 2 trial initiations and the announcement of a significant partnership option deal.These 10 stocks could mint the next wav...
The Motley Fool
Fri, Aug 8
Gencor (GENC) Q3 Profit Jumps 50%
Key PointsRevenue grew 5.6% year over year to $27.0 million (GAAP) in Q3 FY2025, driven by higher contract equipment and parts sales.Gross profit margin expanded by 2.6 percentage points to 26.5% (GAAP) in Q3 FY2025, reflecting improved production efficiency.Backlog dropped to $26.2 million as of Ju...
The Motley Fool
Fri, Aug 8
1
...
570
571
572
572
/
4211
573
574
...
4211
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up